New weekly shot shows promise for shedding pounds in obesity trial
NCT ID NCT07184632
First seen Sep 30, 2025 · Last updated May 21, 2026 · Updated 23 times
Summary
This study tests a new once-weekly medicine called NNC0662-0419 in 224 adults with overweight or obesity. Participants receive either the active drug or a placebo to see if it is safe and helps with weight loss. The main goals are to check for side effects and measure changes in body weight over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion, Lincoln
Lincoln, Nebraska, 68502, United States
-
Celerion, Phoenix
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.